5 of 13 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recently posted filings for this company, out of 13. Reading the whole list, and what each filing says: its issues, the agencies contacted and the lobbyists named, is part of the subscription. So is sorting the list by the reported amount. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Lobbying reported per quarter

reported amounts per quarter, latest version of each report

Reported income: what lobbying firms reported receiving from this company's clients, per quarter.

Reported income

Q1Q2Q3Q4

Recent activity

Register facts only. Everything on this page comes from filings made under the Lobbying Disclosure Act of 1995 and kept by the Secretary of the Senate. We read the filings, we link a client to a listed company where a reviewed rule allows it, and we add nothing else. No score, no ranking and no judgement is attached to lobbying on this site. See the methodology and about this site.

5 of 13 filings

The most recently posted lobbying filings for IMMX
Registrant	Filing	Amount	Posted	Source	Registrant	Amount	Filing	All amounts	Posted	Source
FIRST PRINCIPLES STRATEGIES, LLCfor IMMIX BIOPHARMA, INC.	3rd Quarter - Report3rd Quarter 2026	$20,000incomeposted Oct 20, 2026	Oct 20, 2026	LD-2 at lda.gov	FIRST PRINCIPLES STRATEGIES, LLCfor IMMIX BIOPHARMA, INC.	$20,000income · Oct 20	3rd Quarter - Report3rd Quarter 2026	$20,000income	Oct 20, 2026	LD-2 at lda.gov
FIRST PRINCIPLES STRATEGIES, LLCfor IMMIX BIOPHARMA, INC.	Registration3rd Quarter 2026	no amountregistrationposted Oct 20, 2026	Oct 20, 2026	LD-2 at lda.gov	FIRST PRINCIPLES STRATEGIES, LLCfor IMMIX BIOPHARMA, INC.	no amountregistration · Oct 20	Registration3rd Quarter 2026	no amountregistration	Oct 20, 2026	LD-2 at lda.gov
TARPLIN, DOWNS & YOUNG, LLCfor IMMIX BIOPHARMA INC	3rd Quarter - Report3rd Quarter 2026	$60,000incomeposted Oct 20, 2026	Oct 20, 2026	LD-2 at lda.gov	TARPLIN, DOWNS & YOUNG, LLCfor IMMIX BIOPHARMA INC	$60,000income · Oct 20	3rd Quarter - Report3rd Quarter 2026	$60,000income	Oct 20, 2026	LD-2 at lda.gov
CONTINENTAL STRATEGY, LLCfor IMMIX BIOPHARMA, INC.	3rd Quarter - Report3rd Quarter 2026	$105,000incomeposted Oct 20, 2026	Oct 20, 2026	LD-2 at lda.gov	CONTINENTAL STRATEGY, LLCfor IMMIX BIOPHARMA, INC.	$105,000income · Oct 20	3rd Quarter - Report3rd Quarter 2026	$105,000income	Oct 20, 2026	LD-2 at lda.gov
AXADVOCACY GOVERNMENT RELATIONSfor IMMIX BIOPHARMA INC.	3rd Quarter - Report3rd Quarter 2026	$60,000incomeposted Oct 19, 2026	Oct 19, 2026	LD-2 at lda.gov	AXADVOCACY GOVERNMENT RELATIONSfor IMMIX BIOPHARMA INC.	$60,000income · Oct 19	3rd Quarter - Report3rd Quarter 2026	$60,000income	Oct 19, 2026	LD-2 at lda.gov

The link between the client names above and IMMX is a reviewed rule of ours, not something the filing states: an LD-2 names a client and carries no ticker, no CIK and no LEI.